245 related articles for article (PubMed ID: 21948683)
1. [Prospective study of the correlation of ultrasonography and CA125 in the management of ovarian cysts: a study of 77 cases].
Mathlouthi N; Ben Ayed B; Dhouib M; Chaabene K; Trabelsi K; Amouri H; Guermazi M
Tunis Med; 2011; 89(8-9):686-92. PubMed ID: 21948683
[TBL] [Abstract][Full Text] [Related]
2. Laparoscopic treatment of ovarian cysts in adolescents and young adults.
Seckin B; Ozdener T; Tapisiz OL; Batioğlu S
J Pediatr Adolesc Gynecol; 2011 Oct; 24(5):300-3. PubMed ID: 21715192
[TBL] [Abstract][Full Text] [Related]
3. Pre-operative prediction of serum CA125 level in women with ovarian masses.
Benjapibal M; Neungton C
J Med Assoc Thai; 2007 Oct; 90(10):1986-91. PubMed ID: 18041413
[TBL] [Abstract][Full Text] [Related]
4. Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses.
Moro F; Pasciuto T; Djokovic D; Di Legge A; Granato V; Moruzzi MC; Mancari R; Zannoni GF; Fischerova D; Franchi D; Scambia G; Testa AC
Ultrasound Obstet Gynecol; 2019 Jan; 53(1):116-123. PubMed ID: 29978587
[TBL] [Abstract][Full Text] [Related]
5. Serum C-reactive protein in the differential diagnosis of ovarian masses.
Hefler-Frischmuth K; Hefler LA; Heinze G; Paseka V; Grimm C; Tempfer CB
Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):65-8. PubMed ID: 19619929
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor (VEGF) improves the sensitivity of CA125 for differentiation of epithelial ovarian cancers from ovarian cysts.
Robati M; Ghaderi A; Mehraban M; Shafizad A; Nasrolahi H; Mohammadianpanah M
Arch Gynecol Obstet; 2013 Oct; 288(4):859-65. PubMed ID: 23564055
[TBL] [Abstract][Full Text] [Related]
7. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
[TBL] [Abstract][Full Text] [Related]
8. [Tumor markers and ovarian cysts].
Vinatier D; Houfflin V; Collinet P
J Gynecol Obstet Biol Reprod (Paris); 2001 Nov; 30(1 Suppl):S34-40. PubMed ID: 11917374
[TBL] [Abstract][Full Text] [Related]
9. [Clinical value of serum CA19-9, CA125 and CP2 in mucinous ovarian tumor: a retrospective study of 273 patients].
Dong L; Cui H; Li XP; Sun LF; Chang XH; Liang XD; Zhu HL
Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):5-8. PubMed ID: 18366923
[TBL] [Abstract][Full Text] [Related]
10. [Measurement of serum human epididymis secretory protein 4 combined with CA125 assay in differential diagnosis of endometriosis cyst and ovarian benign and malignant tumors].
Liu YN; Ye X; Cheng HY; Cheng YX; Fu TY; Chen J; Chang XH; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2010 May; 45(5):363-6. PubMed ID: 20646446
[TBL] [Abstract][Full Text] [Related]
11. Immunohistological analysis of stress-induced phosphoprotein 1 in ovarian cancer patients with low serum cancer antigen 125 levels.
Chao A; Lee LY; Hsueh C; Lin CY; Tsai CL; Chao AS; Lin CT; Chou HH; Chang TC; Wang TH
Taiwan J Obstet Gynecol; 2013 Jun; 52(2):185-91. PubMed ID: 23915849
[TBL] [Abstract][Full Text] [Related]
12. Use of serum secretory leukocyte protease inhibitor levels in patients to improve specificity of ovarian cancer diagnosis.
Tsukishiro S; Suzumori N; Nishikawa H; Arakawa A; Suzumori K
Gynecol Oncol; 2005 Feb; 96(2):516-9. PubMed ID: 15661245
[TBL] [Abstract][Full Text] [Related]
13. Preoperative plasma osteopontin level as a biomarker complementary to carbohydrate antigen 125 in predicting ovarian cancer.
Nakae M; Iwamoto I; Fujino T; Maehata Y; Togami S; Yoshinaga M; Douchi T
J Obstet Gynaecol Res; 2006 Jun; 32(3):309-14. PubMed ID: 16764622
[TBL] [Abstract][Full Text] [Related]
14. [Adnexal masses management: a prospective multicentric observational study].
Huchon C; Bats AS; Bensaïd C; Junger M; Nos C; Chatellier G; Lécuru F
Gynecol Obstet Fertil; 2008 Nov; 36(11):1084-90. PubMed ID: 18964176
[TBL] [Abstract][Full Text] [Related]
15. Comparison of plasma amino acid profile-based index and CA125 in the diagnosis of epithelial ovarian cancers and borderline malignant tumors.
Miyagi E; Maruyama Y; Mogami T; Numazaki R; Ikeda A; Yamamoto H; Hirahara F
Int J Clin Oncol; 2017 Feb; 22(1):118-125. PubMed ID: 27623814
[TBL] [Abstract][Full Text] [Related]
16. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group.
Timmerman D; Testa AC; Bourne T; Ferrazzi E; Ameye L; Konstantinovic ML; Van Calster B; Collins WP; Vergote I; Van Huffel S; Valentin L;
J Clin Oncol; 2005 Dec; 23(34):8794-801. PubMed ID: 16314639
[TBL] [Abstract][Full Text] [Related]
17. [Management of dermoid ovarian cysts. Report of 58 cases].
Chechia A; Koubaa A; Makhlouf T; Messaoudi Y; Terras K; Riahi J
Tunis Med; 2002 Mar; 80(3):131-5. PubMed ID: 12355638
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum RANTES levels in patients with ovarian cancer correlate with the extent of the disorder.
Tsukishiro S; Suzumori N; Nishikawa H; Arakawa A; Suzumori K
Gynecol Oncol; 2006 Sep; 102(3):542-5. PubMed ID: 16510173
[TBL] [Abstract][Full Text] [Related]
19. The diagnosis of functional ovarian cysts using transvaginal ultrasound combined with clinical parameters, CA125 determinations, and color Doppler.
Guerriero S; Ajossa S; Lai MP; Alcazar JL; Paoletti AM; Marisa O; Melis GB
Eur J Obstet Gynecol Reprod Biol; 2003 Sep; 110(1):83-8. PubMed ID: 12932878
[TBL] [Abstract][Full Text] [Related]
20. CA 125 in ovarian cysts, serous effusions and peritoneal washings: immunocytochemical expression.
Carico E; Chicchirichi R; Atlante M; Giovagnoli M; Vecchione A
Anticancer Res; 1995; 15(2):631-4. PubMed ID: 7763049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
